Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.
Niyikiza C, Baker SD, Seitz DE, Walling JM, Nelson K, Rusthoven JJ, Stabler SP, Paoletti P, Calvert AH, Allen RH. Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy. Mol Cancer Ther. 2002 May; 1(7):545-52.